CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help cancer patients avoid chemo delays due to low platelets
Disease control OngoingThis phase 2 study tests whether avatrombopag, a drug that boosts platelet production, can safely and effectively treat persistent low platelet counts caused by chemotherapy in people with gastrointestinal cancers. About 60 adults will receive either avatrombopag or a placebo. Th…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug may keep chemo on track for cancer patients
Symptom relief OngoingThis study tests a drug called romiplostim in people with lung, ovarian, or breast cancer who have low platelets from chemotherapy. Low platelets can force doctors to delay or reduce chemo doses. The goal is to see if romiplostim helps patients get their full chemo on schedule. A…
Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC